Medicine & Life Sciences
Fibroblasts
100%
Dinoprostone
88%
Lung
83%
Chemotaxis
65%
Cytokines
64%
human MIRN146 microRNA
58%
Prostaglandins
57%
Hyperlucent Lung
53%
Interleukin-1
51%
Epithelial Cells
50%
Prostaglandins E
50%
efalizumab
50%
Histone Deacetylase 2
48%
Cell Survival
46%
Thrombotic Microangiopathies
41%
Immunoglobulin Light-chain Amyloidosis
41%
Chronic Obstructive Pulmonary Disease
39%
Budesonide
39%
Epithelial-Mesenchymal Transition
37%
Circulating Neoplastic Cells
37%
Pulmonary Embolism
30%
Tumor Necrosis Factor-alpha
28%
Respiratory Insufficiency
28%
MicroRNAs
28%
Cell Movement
28%
Endothelium
27%
Vascular Endothelial Growth Factor A
26%
Apoptosis
23%
Endothelial Cells
22%
Anti-Inflammatory Agents
22%
Neoplasms
17%
Matrix Metalloproteinase 1
16%
Immunosuppressive Agents
15%
Inflammation
14%
Wounds and Injuries
14%
Matrix Metalloproteinases
13%
Gels
12%
Glucocorticoids
12%
Psoriasis
12%
Collagen
11%
human VEGFA protein
10%
Cyclooxygenase 2
10%
Dyspnea
10%
Bronchiectasis
9%
Pneumonectomy
9%
Hemoptysis
8%
Bronchodilator Agents
8%
Segmental Mastectomy
8%
Matrix Metalloproteinase 3
8%
11,15-O-dimethylprostaglandin E2
8%
Chemical Compounds
Prostaglandin E2
82%
Prostaglandin E
71%
Agonist
54%
Cell Viability
30%
Antagonist
24%
Small Interfering RNA
21%
Western Blotting
19%
MicroRNA
18%
Fibronectin
18%
Cell Death
16%
Mixture
8%
KT 5720
8%
Cyclic Amp Dependent Protein Kinase Inhibitor
7%